Govt Job: For Ph.D, M.Pharm, M.Sc as Research Associate at AIIMS

All-India Institute of Medical Sciences (AIIMS) was established as an institution of national importance by an Act of Parliament with the object of developing patterns of teaching in undergraduate and postgraduate medical education in all its branches so as to demonstrate a high standard of medical education in India; bringing together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity, and attaining self-sufficiency in postgraduate medical education. 

The institute has comprehensive facilities for teaching, research, and patient care. As provided in the Act, AIIMS conducts teaching programs in medical and para-medical courses both at undergraduate and postgraduate levels and awards its own degrees.

Post : Research Associate – I

Project Title: “A randomized, open-label, parallel-group study to evaluate the safety and efficacy of abrocitinib 100 mg and 200 mg tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India,” funded by Pfizer.

Project code : N2272
Duration of project : 2 years

Emoluments : As per ICMR guidelines
Place of work : Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi.

Qualifications
i.  Ph.D / MD / MS / MDS OR
ii. MVSc / M.Pharm/ ME / M.Tech having 3 years of research experience with at least one publication in SCI journal

Age Limit : 40 years

Note
1. Only shortlisted candidates will be called for an interview. No TA/DA will be provided.

2. Send your CV with supporting documents in a single PDF file by email at dermatology.aiims12@adarsh

3. Please mention “Application for Research Associate-I in the subject line of the email.

Last date of receiving applications: July 17, till 5 PM.

Related Posts

PGIMS recalls drug amid probe into deaths

The PGIMS authorities have directed all departments to immediately stop using a specific batch of injectable Propofol, an anaesthetic drug, and return the available stock to the central store. The…

NPPA list brings little relief: No price cut for 25% cancer drugs

Mumbai: Nearly one in four cancer drug packs in a revised price list issued by the National Pharmaceutical Pricing Authority (NPPA) has seen no reduction in maximum retail price (MRP),…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

Centre Mandates Minimum One-Year Shelf Life For Imported Drugs

For Aakash Healthcare, Community People are Apples of its Eyes

For Aakash Healthcare, Community People are Apples of its Eyes

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Not mandatory to recall stocks released to the market prior to implementation of TMR: NPPA

Yashoda Medicity: Baby takes a Giant Step in just One Year

Yashoda Medicity: Baby takes a Giant Step in just One Year